These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37018059)

  • 1. Cubosome Lipid Nanocarriers As a Drug Delivery Vehicle for Intracellular
    Sarkar S; Dyett B; Lakic B; Ball AS; Yeo LY; White JF; Soni S; Drummond CJ; Conn CE
    ACS Appl Mater Interfaces; 2023 May; 15(18):21819-21829. PubMed ID: 37018059
    [No Abstract]   [Full Text] [Related]  

  • 2. Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency.
    Pi J; Shen L; Shen H; Yang E; Wang W; Wang R; Huang D; Lee BS; Hu C; Chen C; Jin H; Cai J; Zeng G; Chen ZW
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109777. PubMed ID: 31349400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage targeted graphene oxide nanosystem synergize antibiotic killing and host immune defense for Tuberculosis Therapy.
    Pi J; Chen D; Wang J; Yang E; Yang J; Liu Y; Yu J; Xia J; Huang X; Chen L; Ruan Y; Xu JF; Yang F; Shen L
    Pharmacol Res; 2024 Oct; 208():107379. PubMed ID: 39218421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of Mycobacterium tuberculosis H37Ra-infected immunocompetent mice as an in vivo model of persisters.
    Kumari N; Sharma R; Ali J; Chandra G; Singh S; Krishnan MY
    Tuberculosis (Edinb); 2024 Mar; 145():102479. PubMed ID: 38262199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Heinrichs MT; May RJ; Heider F; Reimers T; B Sy SK; Peloquin CA; Derendorf H
    Int J Mycobacteriol; 2018; 7(2):156-161. PubMed ID: 29900893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GeneXpert
    Christopher PM; ; Widysanto A
    Int J Mycobacteriol; 2019; 8(4):351-358. PubMed ID: 31793505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis.
    Tabriz NS; Skak K; Kassayeva LT; Omarkulov BK; Grigolashvili MA
    Microb Drug Resist; 2020 Aug; 26(8):997-1004. PubMed ID: 32181685
    [No Abstract]   [Full Text] [Related]  

  • 10. Reevaluating Rifampicin Breakpoint Concentrations for Mycobacterium tuberculosis Isolates with Disputed
    Wang W; Liu R; Yao C; Huo F; Shang Y; Zhang X; Wang Y; Xue Z; Ma L; Pang Y
    Microbiol Spectr; 2022 Feb; 10(1):e0208721. PubMed ID: 35107324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
    Mavenyengwa RT; Shaduka E; Maposa I
    Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of Antimycobacterial Activity of Rifampicin Using Mannose-Anchored Lipid Nanoparticles against Intramacrophage Mycobacteria.
    Mistry N; Bandyopadhyaya R; Mehra S
    ACS Appl Bio Mater; 2022 Dec; 5(12):5779-5789. PubMed ID: 36441965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of GeneXpert
    Habous M; E Elimam MA; Kumar R; L Deesi ZA
    Int J Mycobacteriol; 2019; 8(2):132-137. PubMed ID: 31210154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
    Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
    PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of Efflux Pump Genes in Resistant Mycobacterium tuberculosis Complex Clinical Isolates Exposed to First Line Antituberculosis Drugs and Verapamil Combination].
    Özgür D; Ersoy L; Ülger M; Tezcan Ülger S; Aslan G
    Mikrobiyol Bul; 2023 Apr; 57(2):207-219. PubMed ID: 37067206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimycobacterial activity of acetone extract and isolated metabolites from folklore medicinal lichen Usnea laevis Nyl. against drug-sensitive and multidrug-resistant tuberculosis strains.
    Tatipamula VB; Annam SSP
    J Ethnopharmacol; 2022 Jan; 282():114641. PubMed ID: 34536516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea.
    Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T
    Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Subunit Nanovaccine against
    Sarkar S; Mishra A; Periasamy S; Dyett B; Dogra P; Ball AS; Yeo LY; White JF; Wang Z; Cristini V; Jagannath C; Khan A; Soni SK; Drummond CJ; Conn CE
    ACS Appl Mater Interfaces; 2023 Jun; 15(23):27670-27686. PubMed ID: 37262346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.